SCHEMBL7014510

SCHEMBL7014510

CCOC(=O)C(C)CSc1ccc2cc(Cl)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.42
MAPT P10636 3/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP3A4 P08684 4/20 0.40
CYP2C9 P11712 3/20 0.40
CYP2C19 P33261 3/20 0.40
CYP1A2 P05177 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
CYP2D6 P10635 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MAOB P27338 1/20 0.37
TSHR P16473 2/20 0.37
HTR2A P28223 2/20 0.37
PPARD Q03181 2/20 0.37
ABCB11 O95342 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL948935 0.90 ALOX15 (0.43) ALOX15MAPTALDH1A1LMNATDP1
SCHEMBL27041447 0.86 CYP3A4 (0.52) MAPTALDH1A1LMNACYP3A4CYP2C9
SCHEMBL948235 0.81 MTNR1A (0.39) LMNACYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL947915 0.81 MTNR1A (0.39) LMNACYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL27670173 0.78 KMO (0.44) CYP2C9CYP2C19RAB9A
SCHEMBL949305 0.78 KMO (0.44) CYP2C9CYP2C19RAB9A
SCHEMBL949434 0.78 KMO (0.44) CYP2C9CYP2C19RAB9A
SCHEMBL950288 0.77 ALOX15 (0.43) ALOX15MAPTALDH1A1LMNATDP1
SCHEMBL949030 0.77 HTT (0.53) ALOX15MAPTALDH1A1LMNAL3MBTL1
SCHEMBL949028 0.75 ALOX15 (0.41) ALOX15MAPTALDH1A1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1302462-A1 SULFONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2003-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof SULT1E1, RRS1, SHH ALOX15 1872/4885MAPT 4719/4885ALDH1A1 4317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.